查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1612119

过敏诊断市场：按类型、产品类型、测试、最终用户划分 - 全球预测 2025-2030

Allergy Diagnostics Market by Type (Drug Allergen, Food Allergen, Inhaled Allergen), Product Type (Assay Kits, Consumables, Instruments), Test, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年过敏诊断市值为56.3亿美元，预计到2024年将达到59.4亿美元，复合年增长率为5.76%，到2030年将达到83.5亿美元。

过敏诊断市场的范围包括透过各种测试和诊断程序来识别和了解过敏。它包括广泛的诊断测试，包括皮肤点刺测试、血液测试和分解诊断，以检测对各种过敏原（包括花粉、食物和宠物皮屑）的过敏。由于环境和生活方式的变化，过敏性疾病在世界各地不断增加，因此需要过敏诊断。其应用范围广泛，包括个人诊断、药物研究和公共卫生策略的临床环境。最终使用领域主要是医院、诊断实验室和研究机构。影响市场的主要成长要素包括过敏发病率上升、诊断技术的进步以及人们对早期发现和管理过敏性疾病重要性的认识不断提高。机会比比皆是，包括开发更准确、更具成本效益和快速的诊断解决方案，以及将过敏诊断服务扩展到服务不足的地区。研究机构和市场参与者之间的策略联盟有可能进一步扩大市场规模。然而，市场面临严格的监管要求、先进诊断测试的高成本以及新兴市场地区认知度低等挑战。创新领域包括基于奈米的诊断工具和基于基因组的测试方法的进步，这些方法可以准确识别特定的过敏蛋白。鼓励公司投资个人化过敏诊断的研发，因为由于技术创新和全球过敏的流行，市场呈现成长趋势。透过这样做，公司可以提高竞争优势，解决未满足的需求，并为改善患者治疗效果和扩大市场影响铺平道路。

主要市场统计
基准年[2023] 56.3亿美元
预测年份 [2024] 59.4亿美元
预测年份 [2030] 83.5亿美元
复合年增长率（%） 5.76%

市场动态：揭示快速发展的过敏诊断市场的关键市场洞察

供需的动态交互作用正在改变过敏诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界各地过敏患者数量增加以及天气模式变化
    • 政府努力支持过敏意识和诊断解决方案的部署
    • 扩大药局和诊断设施，提供过敏管理解决方案
  • 市场限制因素
    • 某些过敏诊断解决方案和工具发生产品召回
  • 市场机会
    • 持续创新，提高过敏诊断解决方案的准确性和灵敏度
    • 数位和远端医疗平台的扩展以及对个人化诊断解决方案的偏好
  • 市场挑战
    • 与过敏诊断解决方案相关的结果可变和灵敏度低的问题

波特五力：驾驭过敏诊断市场的策略工具

波特的五力框架是了解过敏诊断市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解过敏诊断市场的外部影响

外部宏观环境因素在塑造过敏诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解过敏诊断市场的竞争状况

过敏诊断市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵过敏诊断市场供应商绩效评估

FPNV定位矩阵是评估过敏诊断市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘过敏诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对过敏诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地过敏病例增加和天气模式变化
      • 政府支持引入过敏意识和诊断解决方案的倡议
      • 扩大药局和诊断设施，提供过敏管理解决方案
    • 抑制因素
      • 某些过敏诊断解决方案和工具发生产品召回
    • 机会
      • 持续创新，提高过敏诊断解决方案的准确性和灵敏度
      • 数位和远端医疗平台的扩展以及对个人化诊断解决方案的偏好
    • 任务
      • 与过敏诊断解决方案相关的结果可变和灵敏度低的问题
  • 市场区隔分析
    • 类型：吸入性过敏原在环境中普遍存在，可能导致频繁接触。
    • 最终用户：在政府医疗保健现代化努力的支持下，诊断实验室在世界各地扩展
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章过敏诊断市场：依类型

  • 药物过敏原
  • 食品过敏原
  • 吸入性过敏原

第七章过敏诊断市场：依产品类型

  • 检测试剂套件
  • 消耗品
  • 装置
    • 免疫检测分析仪
    • 光度计

第八章过敏诊断药物市场测试

  • 体外试验
  • 体内测试

第九章过敏诊断市场：依最终用户分类

  • 学术研究所
  • 诊断实验室
  • 院内实验室

第十章北美和南美过敏诊断药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太过敏诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲过敏诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • AllerGenis 在牛奶和管理方面取得革命性进步
    • Metropolis Healthcare 介绍人工智慧驱动的组件解析诊断 (CRD)
    • Dr.Dang实验室使用AI过敏诊断药物介绍Allergynius Dx
  • 战略分析和建议

公司名单

  • ALK-Abello A/S
  • Allergy Therapeutics PLC
  • Astra Biotech GmbH
  • Bausch & Lomb Incorporated
  • Biomerieux SA
  • Danaher Corporation
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • DST Diagnostische Systeme & Technologien GmbH
  • Erba Group by Transasia Bio-Medicals Ltd.
  • Eurofins Scientific SE
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HAL Allergy BV
  • Hitachi, Ltd.
  • HOB Biotech Group Corp., Ltd.
  • HollisterStier by Jubilant Life Sciences Limited
  • HYCOR Biomedical LLC
  • Lincoln Diagnostics, Inc.
  • Minaris Medical America, Inc.
  • Neogen Corporation
  • Omega Diagnostics Group PLC
  • R-Biopharm AG
  • Romer Labs Division Holding GmbH by Royal DSM
  • ROXALL Medizin GmbH
  • Siemens AG
  • Stallergenes Greer International AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-436901065A32

The Allergy Diagnostics Market was valued at USD 5.63 billion in 2023, expected to reach USD 5.94 billion in 2024, and is projected to grow at a CAGR of 5.76%, to USD 8.35 billion by 2030.

The scope of the allergy diagnostics market involves the identification and understanding of allergies through various testing and diagnostic procedures. It encompasses a wide range of diagnostic tests such as skin prick tests, blood tests, and component-resolved diagnostics aimed at detecting allergies to a variety of allergens including pollen, food, and pet dander. The necessity of allergy diagnostics stems from the increasing prevalence of allergic diseases worldwide, driven by environmental and lifestyle changes. Its applications are expansive, encompassing clinical settings for individual diagnosis, pharmaceutical research, and public health strategies. End-use sectors primarily include hospitals, diagnostic laboratories, and research institutes. Key growth factors influencing the market include the rising incidence of allergies, advancements in diagnostic technology, and increasing awareness of the importance of early detection and management of allergic conditions. Opportunities abound in the development of more accurate, cost-effective, and rapid diagnostic solutions, as well as in expanding allergy diagnostic services to underserved regions. Strategic collaborations among research institutes and market players could further amplify market reach. However, the market faces challenges such as stringent regulatory requirements, high costs of advanced diagnostic tests, and limited awareness in developing regions. Areas ripe for innovation include the advancement of nano-based diagnostic tools and genomic-based testing methods that offer precise identification of specific allergenic proteins. As the nature of the market leans towards growth due to technological innovation and increasing global allergy prevalence, businesses are advised to invest in research and development focused on personalized allergy diagnostics. By doing so, firms can enhance their competitive advantage and address unmet needs within allergy diagnostics, paving the way for improved patient outcomes and expanded market presence.

KEY MARKET STATISTICS
Base Year [2023] USD 5.63 billion
Estimated Year [2024] USD 5.94 billion
Forecast Year [2030] USD 8.35 billion
CAGR (%) 5.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Diagnostics Market

The Allergy Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of allergy cases and changes in weather patterns across the world
    • Awareness regarding allergies and government initiatives supporting the deployment of diagnostics solutions
    • Expansion of pharmacies and diagnostics facilities providing allergy management solutions
  • Market Restraints
    • Incidences of product recall of certain allergy diagnostics solutions and tools
  • Market Opportunities
    • Ongoing technological innovations to improve the accuracy and sensitivity of allergy diagnostics solutions
    • Expansion of digital and telehealth platforms and preference for personalized diagnostic solutions
  • Market Challenges
    • Variability in results and low sensitivity issues associated with allergy diagnostics solutions

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Diagnostics Market

A detailed market share analysis in the Allergy Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Diagnostics Market

A strategic analysis of the Allergy Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Diagnostics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Allergy Therapeutics PLC, Astra Biotech GmbH, Bausch & Lomb Incorporated, Biomerieux SA, Danaher Corporation, Dr. Fooke-Achterrath Laboratorien GmbH, DST Diagnostische Systeme & Technologien GmbH, Erba Group by Transasia Bio-Medicals Ltd., Eurofins Scientific SE, EUROIMMUN Medizinische Labordiagnostika AG, HAL Allergy B.V., Hitachi, Ltd., HOB Biotech Group Corp., Ltd., HollisterStier by Jubilant Life Sciences Limited, HYCOR Biomedical LLC, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., Neogen Corporation, Omega Diagnostics Group PLC, R-Biopharm AG, Romer Labs Division Holding GmbH by Royal DSM, ROXALL Medizin GmbH, Siemens AG, Stallergenes Greer International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Allergy Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Drug Allergen, Food Allergen, and Inhaled Allergen.
  • Based on Product Type, market is studied across Assay Kits, Consumables, and Instruments. The Instruments is further studied across Immunoassay Analyzers and Luminometers.
  • Based on Test, market is studied across In-Vitro Tests and In-Vivo Tests.
  • Based on End User, market is studied across Academic Research Institutes, Diagnostic Laboratories, and Hospital-Based Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of allergy cases and changes in weather patterns across the world
      • 5.1.1.2. Awareness regarding allergies and government initiatives supporting the deployment of diagnostics solutions
      • 5.1.1.3. Expansion of pharmacies and diagnostics facilities providing allergy management solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recall of certain allergy diagnostics solutions and tools
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological innovations to improve the accuracy and sensitivity of allergy diagnostics solutions
      • 5.1.3.2. Expansion of digital and telehealth platforms and preference for personalized diagnostic solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Variability in results and low sensitivity issues associated with allergy diagnostics solutions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Ubiquitous nature of inhaled allergens in the environment and chances of frequent exposure
    • 5.2.2. End User: Expansion of diagnostic laboratories across the world supported by government initiatives for modernizing healthcare
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Allergy Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Drug Allergen
  • 6.3. Food Allergen
  • 6.4. Inhaled Allergen

7. Allergy Diagnostics Market, by Product Type

  • 7.1. Introduction
  • 7.2. Assay Kits
  • 7.3. Consumables
  • 7.4. Instruments
    • 7.4.1. Immunoassay Analyzers
    • 7.4.2. Luminometers

8. Allergy Diagnostics Market, by Test

  • 8.1. Introduction
  • 8.2. In-Vitro Tests
  • 8.3. In-Vivo Tests

9. Allergy Diagnostics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Diagnostic Laboratories
  • 9.4. Hospital-Based Laboratories

10. Americas Allergy Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Allergy Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Allergy Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Revolutionary Advancements in Milk Allergy Diagnostics and Management Presented by AllerGenis
    • 13.3.2. Metropolis Healthcare's Introduction of AI-Powered Component Resolved Diagnostics (CRD)
    • 13.3.3. Introduction of Allergynius Dx by Dr. Dang's Lab For Allergy Diagnostics through AI
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ALK-Abello A/S
  • 2. Allergy Therapeutics PLC
  • 3. Astra Biotech GmbH
  • 4. Bausch & Lomb Incorporated
  • 5. Biomerieux SA
  • 6. Danaher Corporation
  • 7. Dr. Fooke-Achterrath Laboratorien GmbH
  • 8. DST Diagnostische Systeme & Technologien GmbH
  • 9. Erba Group by Transasia Bio-Medicals Ltd.
  • 10. Eurofins Scientific SE
  • 11. EUROIMMUN Medizinische Labordiagnostika AG
  • 12. HAL Allergy B.V.
  • 13. Hitachi, Ltd.
  • 14. HOB Biotech Group Corp., Ltd.
  • 15. HollisterStier by Jubilant Life Sciences Limited
  • 16. HYCOR Biomedical LLC
  • 17. Lincoln Diagnostics, Inc.
  • 18. Minaris Medical America, Inc.
  • 19. Neogen Corporation
  • 20. Omega Diagnostics Group PLC
  • 21. R-Biopharm AG
  • 22. Romer Labs Division Holding GmbH by Royal DSM
  • 23. ROXALL Medizin GmbH
  • 24. Siemens AG
  • 25. Stallergenes Greer International AG
  • 26. Tecan Trading AG
  • 27. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ALLERGY DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGY DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALLERGY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGY DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY DRUG ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY FOOD ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY INHALED ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY IN-VITRO TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY IN-VIVO TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023